Discounted prices will be offered at TrumpRx – a new direct-to-consumer website launching next year. It’s a result of deals President Trump recently cut with pharmaceutical giants like Pfizer and AstraZeneca. But who really benefits?

Guests

Dr. Jerry Avorn, professor of Medicine at Harvard Medical School. Author of Rethinking Medications: Truth, Power and the Drugs You Take.

Sarah Emond, president and chief executive officer at the Institute for Clinical and Economic Review (ICER).

The version of our broadcast available at the top of this page and via podcast apps is a condensed version of the full show. You can listen to the full, unedited broadcast here:

The first draft of this transcript was created by Descript, an AI transcription tool. An On Point producer then thoroughly reviewed, corrected, and reformatted the transcript before publication. The use of this AI tool creates the capacity to provide these transcripts.

This program aired on October 16, 2025.